Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-23 2:59 pm Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | Emerald Bioventures LLC | 58,346 5.6% | 58,346 (New Position) | View |
| 2024-04-05 4:00 pm Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital LP | 114,775 9.99% | 114,775 (New Position) | View |
| 2024-02-14 9:13 pm Unchanged | 13G | AVALO THERAPEUTICS INC PAR AVTX | Venrock Healthcare Capital Partners III L.P. | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 4:51 pm Sale | 13G | AVALO THERAPEUTICS INC AVTX | Nantahala Capital Management LLC | 42,100 4.9% | -612,574 (-93.57%) | View |
| 2024-02-14 4:36 pm Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | GREAT POINT PARTNERS LLC | 2,085 0.26% | 2,085 (New Position) | View |
| 2024-02-14 10:02 am Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | Point72 Asset Management L.P. | 2,500 0.3% | 2,500 (New Position) | View |
| 2023-06-29 08:22 am Sale | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 0 0% | -1,475,000 (Position Closed) | View |
| 2023-06-27 6:02 pm Sale | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 623,220 4.99% | -4,159,483 (-86.97%) | View |
| 2023-04-19 4:38 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 1,475,000 11.19% | 81,329 (+5.84%) | View |
| 2023-02-17 4:05 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Venrock Healthcare Capital Partners III L.P. | 1,352,285 9.99% | 1,352,285 (New Position) | View |
| 2023-02-14 4:58 pm Sale | 13G | AVALO THERAPEUTICS INC AVTX | Nantahala Capital Management LLC | 654,674 7% | -7,859,243 (-92.31%) | View |
| 2023-02-14 4:22 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management L.P. | 500,737 5.3% | 500,737 (New Position) | View |
| 2023-02-14 4:09 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 1,393,671 10.57% | 413,113 (+42.13%) | View |
| 2023-02-13 4:10 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | GREAT POINT PARTNERS LLC | 974,639 7.12% | 974,639 (New Position) | View |
| 2023-02-09 4:27 pm Purchase | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 4,782,703 35.4% | 450,333 (+10.39%) | View |
| 2022-08-11 4:09 pm Sale | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 4,332,370 44.4% | -47,656,072 (-91.67%) | View |
| 2022-08-08 07:23 am Sale | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 980,558 10.43% | -5,119,442 (-83.93%) | View |
| 2022-05-17 3:45 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 6,100,000 5.41% | 6,100,000 (New Position) | View |
| 2022-03-15 5:16 pm Purchase | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 51,988,442 44.5% | 1,176,000 (+2.31%) | View |
| 2022-02-14 4:29 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management L.P. | 6,012,676 5.4% | 2,980 (+0.05%) | View |